Lexaria Receives New Patents For Antiviral Drug Delivery and for Treating Epilepsy
Lexaria currently holding 46 granted patents worldwide KELOWNA, BC – Lexaria Bioscience Corp. (NASDAQ:LEXX)(NASDAQ:LEXXW) (the “Company” or “Lexaria”), a global innovator in drug delivery platforms announces three new patent awards…. Read More




